What sector does Merck & Co. Inc (6MK) operate in?
Merck & Co. Inc belongs to the Healthcare sector and operates in the Drug Manufacturers - General industry.
What is Merck & Co. Inc (6MK) current stock price?
As of the latest data, Merck & Co. Inc stock price is €100.60, with a previous close of €100.20. Merck & Co. Inc gained €0.40 in the last trading session, representing a 0.4% increase.
What is Merck & Co. Inc (6MK) current market capitalization?
Merck & Co. Inc market cap is approximately 248.72 billion.
What is Merck & Co. Inc (6MK) Earnings Per Share (EPS)?
The trailing EPS is €6.32.
What is Merck & Co. Inc (6MK) Price-to-Earnings (P/E) ratio?
Merck & Co. Inc current P/E ratio is 15.92.
What is Merck & Co. Inc (6MK) EBITDA?
Merck & Co. Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 7.34 billion.
Does Merck & Co. Inc (6MK) pay dividends?
Yes. Merck & Co. Inc pays quarterly dividends with an annualized yield of 2.54% and an estimated annual payout of €2.95 per share.
When is the next ex-dividend date for Merck & Co. Inc (6MK)?
The next ex-dividend date is scheduled for March 16, 2026.
How did Merck & Co. Inc (6MK) perform in its most recent earnings report?
In the last report (December 31, 2025), Merck & Co. Inc posted an EPS surprise of -49.09% and a revenue surprise of -78.45%.
When is Merck & Co. Inc (6MK) next earnings report?
Merck & Co. Inc is expected to release its next earnings report on March 31, 2026.
What is Merck & Co. Inc (6MK) beta (volatility) score?
Merck & Co. Inc has a beta of 0.264, indicating lower volatility than the overall market.